Join Professor John Camm and Dr Michael Ezekowitz for a discussion of the optimal anticoagulation strategy for a real-life patient case undergoing cardioversion for atrial fibrillation.
In this video, filmed at ACC 2018, Professor John Camm and Dr Michael Ezekowitz discuss the case of a 78-year old male with well-controlled hypertension who presented to the emergency department with palpitations. Discover the anticoagulation approach taken for this patient after an EKG confirmed atrial fibrillation and a cardioversion was planned. The risks and benefits of warfarin versus non-vitamin K oral anticoagulants (NOACs) are also explored, before an in-depth discussion into the optimal NOAC dosage before and after cardioversion.
This educational activity is designed for hospitalists, haematologists, interventional cardiologists, internists/physicians, surgeons and any other healthcare professional with an interest or role in the management of patients on anticoagulation undergoing cardioversion for atrial fibrillation.
Learning objectives After completing this educational activity, participants should be able to:
Missed a live event? All journal club recordings can be accessed here to explore or revisit in your own time via our eLearning platform.